Pathophysiology and Management of Parkinsonian Tremor

Abstract

Parkinson's tremor is one of the cardinal motor symptoms of Parkinson's disease. The pathophysiology of Parkinson's tremor is different from that of other motor symptoms such as bradykinesia and rigidity. In this review, the authors discuss evidence suggesting that tremor is a network disorder that arises from distinct pathophysiological changes in the basal ganglia and in the cerebellothalamocortical circuit. They also discuss how interventions in this circuitry, for example, deep brain surgery and noninvasive brain stimulation, can modulate or even treat tremor. Future research may focus on understanding sources for the large variability between patients in terms of treatment response, on understanding the contextual factors that modulate tremor (stress, voluntary movements), and on focused interventions in the tremor circuitry.

Keywords

Parkinson's disease - tremor - basal ganglia - treatment

• References

• 1 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Arch Neurol 2001; 58 (10) 1630-1634
• 2 Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson disease. Arch Neurol 1999; 56 (3) 334-337
• 3 Koh S-B, Kwon D-Y, Seo W-K , et al. Dissociation of cardinal motor signs in Parkinson's disease patients. Eur Neurol 2010; 63 (5) 307-310
• 4 Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?. Mov Disord 2003; 18 (Suppl. 07) S43-S51
• 5 Nonnekes J, Timmer MHM, de Vries NM, Rascol O, Helmich RC, Bloem BR. Unmasking levodopa resistance in Parkinson's disease. Mov Disord 2016; 31 (11) 1602-1609
• 6 Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?. Brain 2012; 135 (Pt 11): 3206-3226
• 7 Zach H, Dirkx M, Bloem BR, Helmich RC. The clinical evaluation of Parkinson's tremor. J Parkinsons Dis 2015; 5 (3) 471-474
• 8 Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67 (5) 646-650
• 9 Louis ED, Frucht SJ. Prevalence of essential tremor in patients with Parkinson's disease vs. Parkinson-plus syndromes. Mov Disord 2007; 22 (10) 1402-1407
• 10 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318 (14) 876-880
• 11 Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012; 27 (1) 8-30
• 12 Deutch AY, Elsworth JD, Goldstein M , et al. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci Lett 1986; 68 (1) 51-56
• 13 German DC, Dubach M, Askari S, Speciale SG, Bowden DM. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?. Neuroscience 1988; 24 (1) 161-174
• 14 Williams SM, Goldman-Rakic PS. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 1998; 8 (4) 321-345
• 15 Jan C, François C, Tandé D , et al. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur J Neurosci 2000; 12 (12) 4525-4535
• 16 François C, Savy C, Jan C, Tande D, Hirsch EC, Yelnik J. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients. J Comp Neurol 2000; 425 (1) 121-129
• 17 François C, Yelnik J, Tandé D, Agid Y, Hirsch EC. Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum. J Comp Neurol 1999; 414 (3) 334-347
• 18 Sánchez-González MA, García-Cabezas MA, Rico B, Cavada C. The primate thalamus is a key target for brain dopamine. J Neurosci 2005; 25 (26) 6076-6083
• 19 Helmich RC, Janssen MJR, Oyen WJG, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 2011; 69 (2) 269-281
• 20 Dirkx MF, den Ouden HE, Aarts E , et al. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain 2017 ePub ahead of print
• 21 Doder M, Rabiner EA, Turjanski N, Lees AJ, Brooks DJ ; 11C-WAY 100635 PET study. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 2003; 60 (4) 601-605
• 22 Qamhawi Z, Towey D, Shah B , et al. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain 2015; 138 (Pt 10): 2964-2973
• 23 Caretti V, Stoffers D, Winogrodzka A , et al. Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]β-CIT SPECT study. J Neural Transm (Vienna) 2008; 115 (5) 721-729
• 24 Isaias IU, Marzegan A, Pezzoli G , et al. A role for locus coeruleus in Parkinson tremor. Front Hum Neurosci 2012; 5: 179
• 25 Raethjen J, Austermann K, Witt K, Zeuner KE, Papengut F, Deuschl G. Provocation of Parkinsonian tremor. Mov Disord 2008; 23 (7) 1019-1023
• 26 Zach H, Dirkx MF, Pasman JW, Bloem BR, Helmich RC. Cognitive stress reduces the effect of levodopa on Parkinson's resting tremor. CNS Neurosci Ther 2017; 23 (3) 209-215
• 27 Zach H, Dirkx M, Pasman JW, Bloem BR, Helmich RC. The patient's perspective: the effect of levodopa on Parkinson symptoms. Parkinsonism Relat Disord 2017; 35: 48-54
• 28 Barcroft H, Peterson E, Schwab RS. Action of adrenaline and noradrenaline on the tremor in Parkinson's disease. Neurology 1952; 2 (2) 154-160
• 29 Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24 (2) 197-211
• 30 Delaville C, Deurwaerdère PD, Benazzouz A. Noradrenaline and Parkinson's disease. Front Syst Neurosci 2011; 5: 31
• 31 Katzenschlager R, Sampaio C, Costa J, Lees A. Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev 2003; (2) CD003735
• 32 Perez-Lloret S, Barrantes FJ. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease. Parkinsons Dis 2016; 2: 16001
• 33 Elble RJ. Central mechanisms of tremor. J Clin Neurophysiol 1996; 13 (2) 133-144
• 34 Lozano AM, Lang AE, Galvez-Jimenez N , et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995; 346 (8987): 1383-1387
• 35 Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 1997; 350 (9092): 1675
• 36 Benabid AL, Pollak P, Gervason C , et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337 (8738): 403-406
• 37 Levy R, Hutchison WD, Lozano AM, Dostrovsky JO. High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 2000; 20 (20) 7766-7775
• 38 Raz A, Vaadia E, Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000; 20 (22) 8559-8571
• 39 Lenz FA, Kwan HC, Martin RL, Tasker RR, Dostrovsky JO, Lenz YE. Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells. Brain 1994; 117 (Pt 3): 531-543
• 40 Hirschmann J, Hartmann CJ, Butz M , et al. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease. Brain 2013; 136 (Pt 12): 3659-3670
• 41 Timmermann L, Gross J, Dirks M, Volkmann J, Freund HJ, Schnitzler A. The cerebral oscillatory network of parkinsonian resting tremor. Brain 2003; 126 (Pt 1): 199-212
• 42 Hurtado JM, Gray CM, Tamas LB, Sigvardt KA. Dynamics of tremor-related oscillations in the human globus pallidus: a single case study. Proc Natl Acad Sci U S A 1999; 96 (4) 1674-1679
• 43 Mure H, Hirano S, Tang CC , et al. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage 2011; 54 (2) 1244-1253
• 44 Dirkx MF, den Ouden H, Aarts E , et al. The cerebral network of Parkinson's tremor: an effective connectivity fMRI study. J Neurosci 2016; 36 (19) 5362-5372
• 45 Jahnsen H, Llinás R. Ionic basis for the electro-responsiveness and oscillatory properties of guinea-pig thalamic neurones in vitro. J Physiol 1984; 349 (1) 227-247
• 46 Llinás RR. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science 1988; 242 (4886): 1654-1664
• 47 Magnin M, Morel A, Jeanmonod D. Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience 2000; 96 (3) 549-564
• 48 Bergman H, Feingold A, Nini A , et al. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci 1998; 21 (1) 32-38
• 49 Jenkinson N, Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci 2011; 34 (12) 611-618
• 50 Plenz D, Kital ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999; 400 (6745): 677-682
• 51 Cagnan H, Brittain JS, Little S , et al. Phase dependent modulation of tremor amplitude in essential tremor through thalamic stimulation. Brain 2013; 136 (Pt 10): 3062-3075
• 52 Cagnan H, Little S, Foltynie T , et al. The nature of tremor circuits in parkinsonian and essential tremor. Brain 2014; 137 (Pt 12): 3223-3234
• 53 Brittain J-S, Probert-Smith P, Aziz TZ, Brown P. Tremor suppression by rhythmic transcranial current stimulation. Curr Biol 2013; 23 (5) 436-440
• 54 Brittain JS, Cagnan H, Mehta AR, Saifee TA, Edwards MJ, Brown P. Distinguishing the central drive to tremor in Parkinson's disease and essential tremor. J Neurosci 2015; 35 (2) 795-806
• 55 Duval C, Daneault J-F, Hutchison WD, Sadikot AF. A brain network model explaining tremor in Parkinson's disease. Neurobiol Dis 2016; 85: 49-59
• 56 Raethjen J, Pohle S, Govindan RB, Morsnowski A, Wenzelburger R, Deuschl G. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response. Exp Neurol 2005; 194 (1) 151-160
• 57 Schlesinger I, Benyakov O, Erikh I, Suraiya S, Schiller Y. Parkinson's disease tremor is diminished with relaxation guided imagery. Mov Disord 2009; 24 (14) 2059-2062
• 58 Deuschl G, Bain P, Brin M ; Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on Tremor. Mov Disord 1998; 13 (Suppl. 03) 2-23
• 59 Crosby NJ, Deane KH, Clarke CE. Beta-blocker therapy for tremor in Parkinson's disease. Cochrane Database Syst Rev 2003; 1 (1) CD003361
• 60 Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014; 311 (16) 1670-1683
• 61 Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain 1992; 115 (Pt 6): 1701-1725
• 62 Koller WC. Pharmacologic treatment of parkinsonian tremor. Arch Neurol 1986; 43 (2) 126-127
• 63 Pogarell O, Gasser T, van Hilten JJ , et al. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. J Neurol Neurosurg Psychiatry 2002; 72 (6) 713-720
• 64 Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114 (Pt 5): 2095-2122
• 65 Lozano AM, Dostrovsky J, Chen R, Ashby P. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol 2002; 1 (4) 225-231
• 66 Sturman MM, Vaillancourt DE, Metman LV, Bakay RA, Corcos DM. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease. Brain 2004; 127 (Pt 9): 2131-2143
• 67 Krause M, Fogel W, Heck A , et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001; 70 (4) 464-470
• 68 Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999; 45 (6) 1375-1382 , discussion 1382–1384
• 69 Katz M, Luciano MS, Carlson K , et al; CSP 468 study group. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Ann Neurol 2015; 77 (4) 710-719
• 70 Elias WJ, Lipsman N, Ondo WG , et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2016; 375 (8) 730-739
• 71 Weintraub D, Elias WJ. The emerging role of transcranial magnetic resonance imaging-guided focused ultrasound in functional neurosurgery. Mov Disord 2017; 32 (1) 20-27
• 72 Hirschmann J, Butz M, Hartmann CJ , et al. Parkinsonian rest tremor is associated with modulations of subthalamic high-frequency oscillations. Mov Disord 2016; 31 (10) 1551-1559
• 73 Coenen VA, Allert N, Paus S, Kronenbürger M, Urbach H, Mädler B. Modulation of the cerebello-thalamo-cortical network in thalamic deep brain stimulation for tremor: a diffusion tensor imaging study. Neurosurgery 2014; 75 (6) 657-669 , discussion 669–670
• 74 Klein JC, Barbe MT, Seifried C , et al. The tremor network targeted by successful VIM deep brain stimulation in humans. Neurology 2012; 78 (11) 787-795
• 75 Sammartino F, Krishna V, King NKK , et al. Tractography-based ventral intermediate nucleus targeting: novel methodology and intraoperative validation. Mov Disord 2016; 31 (8) 1217-1225
• 76 Probst-Cousin S, Druschky A, Neundörfer B. Disappearance of resting tremor after “stereotaxic” thalamic stroke. Neurology 2003; 61 (7) 1013-1014
• 77 Kim D-G, Koo Y-H, Kim O-J, Oh S-H. Development of Holmes' tremor in a patient with Parkinson's disease following acute cerebellar infarction. Mov Disord 2009; 24 (3) 463-464
• 78 Deuschl G, Wilms H, Krack P, Würker M, Heiss WD. Function of the cerebellum in Parkinsonian rest tremor and Holmes' tremor. Ann Neurol 1999; 46 (1) 126-128
• 79 Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol 2010; 68 (6) 816-824
• 80 Britton TC, Thompson PD, Day BL, Rothwell JC, Findley LJ, Marsden CD. Modulation of postural wrist tremors by magnetic stimulation of the motor cortex in patients with Parkinson's disease or essential tremor and in normal subjects mimicking tremor. Ann Neurol 1993; 33 (5) 473-479
• 81 Obeso I, Cerasa A, Quattrone A. The effectiveness of transcranial brain stimulation in improving clinical signs of hyperkinetic movement disorders. Front Neurosci 2016; 9: 486
• 82 Bologna M, Di Biasio F, Conte A, Iezzi E, Modugno N, Berardelli A. Effects of cerebellar continuous theta burst stimulation on resting tremor in Parkinson's disease. Parkinsonism Relat Disord 2015; 21 (9) 1061-1066